MedPath

To study the effect of Dashamoola Siddha Taila Matrabasti and Uttarbasti in the management of Mootraghata W.S.R. to Benign Prostatic Hyperplasia

Phase 2
Completed
Conditions
Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
Registration Number
CTRI/2022/07/043639
Lead Sponsor
Government Akhandanand Ayurved College Ahmedabad
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

1. Patients presenting with classical signs and symptoms of

Mootraghata/BPH like Incomplete emptying, Increased Frequency,

Intermittency, Urgency, Weak stream,Straining, Nocturia, Painful

mituration, Burning micturition

2. Male patient Age between 40-80 year

3. Controlled case of Diabetes mellitus (RBS upto 180 mg/dl) and

Hypertension (upto 150/90 mm Hg)

Exclusion Criteria

1. CA Prostate

2. Urethral stricture

3. Benign tumour of urethra

4. Malignant tumour of urethra

5. Urethral injury, urethral calculi

6. Age above 80 years and below 40 years

7. Patients with systemic diseases like uncontrolled Hypertension (more

than 150/90 mm Hg) and uncontrolled Diabetes mellitus (RBS more than

180 mg/dl),Tuberculosis, VDRL, STD, HIV, HBsAg

8. Known case of heart disease

9. According Ayurveda point of view, Matrabasti should not be

administered in the persons having Ajirna and who has slept during

day time

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Result will be assased on the basis of relief sign and symptoms of Mootraghata <br/ ><br> <br/ ><br>ResultDescription <br/ ><br>Subjective Criteria :- <br/ ><br>International Prostate Symptom Score (IPSS) <br/ ><br> <br/ ><br>Objective Criteria :- <br/ ><br>Prostatic size (volume) <br/ ><br>Urine Flow Rate <br/ ><br>Residual Urine Volume <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: 21 Days
Secondary Outcome Measures
NameTimeMethod
Comparing the effect of both procedures in the management of Mootraghata <br/ ><br>ResultDescription: <br/ ><br>Complete cure - 100% relief in subjective, objective findings and IPSS parameters <br/ ><br>Maximum improvement - 76% to 100% relief in subjective, objective findings and IPSS parameters <br/ ><br>Moderate improvement - 51% to 75% relief in subjective, objectivefindings and IPSS parameters <br/ ><br>Mild improvement - 26% to 50% relief in subjective, objective findings and IPSS parameters <br/ ><br>Unchanged - Up to 25% relief in subjective, objectivefindings and IPSS parametersTimepoint: 2 weeks
© Copyright 2025. All Rights Reserved by MedPath